The research, published in the journal Nature Medicine, also found that the antibody profile in the blood of people who have ...

When it comes to fighting COVID-19, scientists are throwing every bit of science we’ve got at it. A creative technique some ...

A neurologist explains how Multiple Sclerosis begins, the early symptoms to watch out for, and current treatment options that ...

Data demonstrates neflamapimod treatment led to significant reductions in plasma glial fibrillary acidic protein ( GFAP), a key marker of neuroinflammation-associated neurodegeneration, and increased ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

Diana Hussain, MD, FAAPMR, DABPM Florida Wellness & Regenerative Medicine ABOUT THE DOCTOR Dr. Diana Hussain completed her ...

Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...

A brave boy who was suddenly paralysed from the waist down by a rare spinal condition is determined to get back on the rugby ...

Bioventus is regaining stability after a volatile period, with improving margins and organic sales growth driving renewed ...

Late-breaking oral presentation by a leading global authority in Dementia with Lewy bodies (DLB) to highlight updated data from Phase 2b study on neflamapimod treatment for DLB. N ...

Tom Nolan reviews this week’s research Social media platforms are awash with influencers promoting cures for all ills. They often make claims that would breach advertising rules—particularly in the ...